Related Experiment Video
Updated: Feb 25, 2026
Transabdominal Ultrasound for Pregnancy Diagnosis in Reeves' Muntjac Deer
Published on: January 7, 2014
[The gestational age label]
1Universitair Medisch Centrum Groningen-Rijksuniversiteit Groningen, afd. Kindergeneeskunde, Groningen.
Insights
Dutch guidelines limit treatment for premature infants under 24 weeks gestation, showing positive outcomes. However, using gestational age alone for treatment decisions in extremely premature babies is ethically debated, suggesting a personalized approach is needed.
Area of Science:
- Neonatal Medicine
- Medical Ethics
- Perinatal Policy
Background:
- National guidelines in the Netherlands restrict treatment for infants born before 24 weeks gestation.
- Recent data indicates encouraging outcomes for babies born after 24 weeks gestation under these policies.
Purpose of the Study:
- To evaluate the scientific and ethical basis of using gestational age as a sole criterion for limiting treatment in extremely premature infants.
- To propose an alternative approach to decision-making for the treatment of extremely premature neonates.
Main Methods:
- Analysis of follow-up data for infants born above 24 weeks gestation.
- Ethical and scientific review of current treatment limitation policies based on gestational age.
Main Results:
- Encouraging outcomes observed in infants born after 24 weeks gestation align with current Dutch policy.
- The scientific and ethical justification for using gestational age as a strict cut-off is questioned.
Conclusions:
- Gestational age alone is a questionable basis for determining treatment for extremely premature infants.
- A personalized, ethically informed approach by trained clinicians is recommended for complex neonatal decisions, regardless of gestational age.
Abstract:
Recent follow-up data on babies born at > 24 weeks' gestation in the Netherlands has shown encouraging results; these outcomes reflect policy in national guidelines to limit treatment in babies born at < 24 weeks' gestation. The use of gestational age as a cut-off point for active treatment in extremely premature infants is, however, scientifically and ethically questionable. As an alternative we should consider a tailor-made approach by well-informed, ethically trained doctors who feel comfortable with complex decision-making, irrespective of the gestational age label.
